Contact UsResearch
6G Networks
Designing and optimizing networked systems to further society’s digital transformation.
Systems Platforms for AI
Improving data architectures and frameworks. Developing technology for AI and parallel computing that intersects domain-specific programming languages and software engineering.Case Studies
Discover how our research is advancing science and technology.
NEC Brings Faster Ticket Resolution to its SaaS-based ITSM platform with AI-Driven Ticket Intelligence
NEC brings AI-driven ticket intelligence to its IT service management platform, helping customers automate resolutions, reuse knowledge, and handle tickets more efficiently at scale.
NEC improves cyber threat monitoring using AutoReport by NEC
NEC implements AutoReport by NEC Laboratories Europe within its cybersecurity operations, automating cyber threat intelligence and cutting investigation time by 50%.
Avaloq enhances corporate action processing with advanced AI innovation
Avaloq implements GenAI Corporate Actions for Banking Operations to automate the processing of corporate actions, reducing manual effort and human error while improving operational efficiency. This innovation helps pave the way for broader AI adoption across banking operations.
About us
We find new ways to push the boundaries of science, delivering technology that significantly benefits the environment, society and our lives.
Our researchers choose their own projects, lead scientific discovery and regularly present their results at top, peer-reviewed scientific conferences. We are committed to open-innovation technology that benefits science and society.
Technology
Learn how our technology is helping to solve society’s greatest challenges.
Pioneering Graph-Based Relational Learning
NEC Laboratories Europe is a world pioneer in advancing and applying graph-based relational learning. Our GraphAI technology discovers and exploits relations between data entities, eliminating the problem of missing data points and linking multimodal data.
Accelerating Vaccine Discovery with Software Optimization
Governments and scientists are in a race against time to identify and control the spread of emerging viruses before they become pandemics. NEC Laboratories Europe is currently working with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop vaccines effective against SARS-CoV-2 variants and other betacoronaviruses.
A New Frontier in Personalized Therapeutic Cancer Vaccines
Neoantigens can be used to develop personalized therapeutic cancer vaccines that teach the patient's immune system to recognize and kill cancer cells. The NEC Neoantigen Prediction Pipeline uses bioinformatics and machine learning to analyze the DNA and RNA of cancer patients to identify neoantigens originating from cancer mutations. NEC Laboratories Europe was a key contributor in developing the prediction pipeline, which enables NEC biotech partners to advance immunotherapy.